ADMA Biologics, Inc. ( ADMA) - Key Metrics
ADMA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.58 | $0.21 | $0.15 | $0.15 |
| 2025Q3 | $0.56 | $0.15 | $0.06 | $0 |
| 2025Q2 | $0.51 | $0.14 | $0.09 | $0.08 |
| 2025Q1 | $0.48 | $0.11 | -$0.08 | -$0.10 |
ADMA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 21.98 |
| 2025Q3 | ? | 24.01 |
| 2025Q2 | ? | 32.13 |
| 2025Q1 | ? | 43.84 |
ADMA Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.62% | ? |
| 2025Q4 | 0.80% | ? |
| 2025Q3 | -0.03% | ? |
| 2025Q2 | 0.43% | ? |
| 2025Q1 | -0.52% | ? |
ADMA
Price: $8.50
52 week price:
Earnings Per Share: 0.68 USD
P/E Ratio: 11.59
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 2.7 million
Ebitda: -13.6 millionMarket Capitalization: 1.9 billion